Cargando…
Zileuton, 5-Lipoxygenase Inhibitor, Acts as a Chemopreventive Agent in Intestinal Polyposis, by Modulating Polyp and Systemic Inflammation
PURPOSE: Leukotrienes and prostaglandins, products of arachidonic acid metabolism, sustain both systemic and lesion-localized inflammation. Tumor-associated Inflammation can also contribute to the pathogenesis of colon cancer. Patients with inflammatory bowel disease (IBD) have increased risk of dev...
Autores principales: | Gounaris, Elias, Heiferman, Michael J., Heiferman, Jeffrey R., Shrivastav, Manisha, Vitello, Dominic, Blatner, Nichole R., Knab, Lawrence M., Phillips, Joseph D., Cheon, Eric C., Grippo, Paul J., Khazaie, Khashayarsha, Munshi, Hidayatullah G., Bentrem, David J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4351892/ https://www.ncbi.nlm.nih.gov/pubmed/25747113 http://dx.doi.org/10.1371/journal.pone.0121402 |
Ejemplares similares
-
The two faces of regulatory T cells in cancer
por: Blatner, Nichole R, et al.
Publicado: (2013) -
Inhibition of 5-lipoxygenase by zileuton in a rat model of myocardial infarction
por: Abueid, Leyla, et al.
Publicado: (2017) -
New Zileuton-Hydroxycinnamic Acid Hybrids: Synthesis and Structure-Activity Relationship towards 5-Lipoxygenase Inhibition
por: Chiasson, Audrey Isabel, et al.
Publicado: (2020) -
The 5-Lipoxygenase Inhibitor Zileuton Protects Pressure Overload-Induced Cardiac Remodeling via Activating PPARα
por: Wu, Qing-Qing, et al.
Publicado: (2019) -
Inhibition of 5-lipoxygenase inhibitor zileuton in high-fat diet-induced nonalcoholic fatty liver disease progression model
por: Ma, Kuifen, et al.
Publicado: (2017)